Home » Healthcare » Egypt In-Vitro Fertilization (IVF) Market

Egypt In-Vitro Fertilization (IVF) Market By Product (Equipment, Reagents and Media, Accessories); By Cycle (Fresh Non-donor IVF Cycles, Frozen Non-donor IVF Cycles, Frozen Donor IVF Cycles, Fresh Donor IVF Cycle); By Type (Conventional IVF, IVF with ICSI, IVF with Donor Eggs, Others); By End-User (Fertility Clinics, Hospitals & Surgical Centers, Cryobanks, Research Institutes); By Geography – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Price: $1999

Published: | Report ID: 38526 | Report Format : PDF
REPORT ATTRIBUTE DETAILS
Historical Period  2019-2022
Base Year  2023
Forecast Period  2024-2032
Egypt In-Vitro Fertilization Market Size 2023  USD 487.21 Million
Egypt In-Vitro Fertilization Market, CAGR  7.80%
Egypt In-Vitro Fertilization Market Size 2032  USD 957.82 Million

Market Overview

The Egypt In-Vitro Fertilization (IVF) market is projected to grow from USD 487.21 million in 2023 to USD 957.82 million by 2032, reflecting a robust compound annual growth rate of 7.80%.

The Egypt In-Vitro Fertilization (IVF) market is experiencing significant growth driven by several key factors. Increasing awareness and acceptance of IVF procedures among the populace, coupled with rising infertility rates due to factors such as lifestyle changes and delayed childbearing, are driving demand. Additionally, advancements in IVF technologies and procedures, including the introduction of preimplantation genetic testing and improved success rates, are further propelling market expansion. Moreover, supportive government initiatives and favorable reimbursement policies are encouraging accessibility to IVF treatments, contributing to the market’s upward trajectory.

In the geographical analysis of the Egypt In-Vitro Fertilization (IVF) market, urban centers like Cairo and Alexandria emerge as major hubs due to higher population densities and better healthcare infrastructure. These regions witness a significant concentration of IVF clinics and fertility centers, catering to a larger pool of potential patients. Key players in the Egyptian IVF market include renowned healthcare institutions such as Cook Medical, Inc., Vitrolife AB, Irvine Scientific, and EMD Serono, Inc., which dominate the landscape with their advanced technologies, experienced medical professionals, and established reputations for high success rates in fertility treatments.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Market Drivers

Rising Age of Mothers

Similar to global trends, Egyptian women are waiting longer to have children due to pursuing education, careers, or delaying marriage. For instance, recent data indicates that the fertility rate in Egypt has declined to 2.8 births per woman in 2021, a 20% drop from 3.5 births per woman in 2014. This decline is attributed to factors such as increased female education and career opportunities, which have led to women delaying childbirth. As a result, the demand for IVF services has grown, with the Egyptian IVF Center reporting 4,993 fresh IVF cycles and 2,500 frozen embryo transfers in 2022. This can lead to fertility issues as women age. Consequently, there’s a notable shift in the demographic landscape, with more women seeking fertility treatments later in life. This trend underscores the increasing importance of IVF services in addressing age-related fertility challenges among Egyptian couples.

Increased Awareness

There’s a growing awareness about infertility and the availability of IVF as a treatment option, leading more couples to seek these services. The growing awareness of infertility issues is reflected in the fact that 54.6% of men and 62.4% of women have heard about oocyte cryopreservation, a key component of IVF, although only 13.8% of men and 14.4% of women have a satisfactory level of knowledge regarding the procedure. This highlights the need for increased education and counseling on fertility options. As societal attitudes toward infertility evolve, individuals are becoming more proactive in seeking solutions. This heightened awareness is driving an uptick in demand for IVF procedures across Egypt, as couples recognize IVF as a viable pathway to parenthood and are increasingly willing to explore these options.

Declining Fertility Rates

Several factors like stress, pollution, smoking, and obesity are contributing to a decrease in overall fertility rates in Egypt. For instance, research has shown that lifestyle factors such as stress, pollution, smoking, and obesity can significantly impact fertility rates. In Egypt, these factors are contributing to a noticeable decline in fertility, with studies indicating that stress can lead to a decrease in female fertility. Pollution and chemical exposure have also been linked to increased infertility. Smoking is known to adversely affect reproductive health, and obesity has been associated with a higher risk of infertility. IVF (In Vitro Fertilization) has become an increasingly important solution for couples facing these challenges. In Egypt, IVF success rates are impressive, with some fertility centers reporting success rates exceeding 40%, aligning with international standards. The success rates of IVF in Egypt are comparable to those in some of the largest centers in the United States and Europe, with pregnancy rates ranging between 50% to 60%. With the prevalence of lifestyle factors impacting fertility, IVF serves as a crucial medical intervention, providing hope for couples struggling to conceive naturally amidst declining fertility rates.

Technological Advancements

Developments in IVF techniques like improved embryo selection and freezing methods are making the procedures more successful, driving demand. Technological advancements in the field of assisted reproductive technology have significantly enhanced the efficacy and success rates of IVF treatments. These advancements not only improve outcomes but also instill confidence in couples considering IVF as a viable option to fulfill their dream of starting a family.

Market Trends

Shifting Procedures

The market is witnessing a rise in ICSI (Intracytoplasmic Sperm Injection) procedures within IVF. ICSI offers higher fertilization rates, making it a growing segment within the market. For instance, the IVF market has seen a significant rise in the use of ICSI procedures, with an estimated 75% of all IVF procedures in the U.S. incorporating ICSI in 2018. This trend is indicative of a global shift towards ICSI, as it offers higher fertilization rates, especially in cases of male factor infertility. As advancements in IVF techniques continue to evolve, the adoption of ICSI procedures is on the rise due to its proven efficacy in addressing male factor infertility and other complex fertility issues. This shift towards ICSI reflects a growing preference among both patients and healthcare providers for procedures that offer enhanced success rates and improved outcomes, driving the expansion of this particular segment within the IVF market.

Focus on Fertility Clinics

Fertility clinics are indeed becoming the dominant service providers for IVF procedures. In Egypt, the oldest and most experienced fertility clinic, the Egyptian IVF Center, carried out 4,993 fresh IVF cycles and 2,500 frozen embryo transfers in 2022. These clinics offer personalized care tailored to the unique needs of each patient, fostering trust and confidence among couples seeking fertility treatments. Their focus on personalized care and the ability to cater to the unique needs of each patient make them the preferred choice for many couples seeking fertility treatments. As such, fertility clinics are expected to continue playing a pivotal role in the IVF market, maintaining their position as key players in the delivery of IVF services across Egypt and beyond.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Market Challenges Analysis

High Cost of Treatment

IVF procedures are expensive, encompassing medication, lab fees, doctor consultations, and potential additional cycles if needed. This limits access for a significant portion of the Egyptian population, especially those with lower incomes. The financial burden associated with IVF can be prohibitive for many couples, particularly those from lower socioeconomic backgrounds. The cumulative costs involved in multiple IVF cycles, coupled with the absence of adequate financial assistance or subsidies, present significant challenges for individuals seeking fertility treatments in Egypt. As a result, affordability remains a critical barrier to accessing IVF services for a considerable segment of the population.

Limited Insurance Coverage

In many cases, insurance plans don’t cover IVF treatment, placing the financial burden solely on patients. This lack of coverage is a major barrier for many seeking this option. The absence of comprehensive insurance coverage for IVF treatments further exacerbates the financial strain on patients, forcing them to bear the full cost of treatment out-of-pocket. Without adequate insurance support, individuals and couples are often confronted with difficult decisions regarding their fertility journey, potentially delaying or forgoing treatment altogether due to financial constraints. Addressing the issue of limited insurance coverage is essential to ensuring equitable access to IVF services for all individuals in need.

Social Stigma

Infertility can be a sensitive topic in Egyptian society, and some couples might hesitate to seek IVF due to social stigma or cultural beliefs surrounding infertility treatments. The societal taboo surrounding infertility can lead to feelings of shame, guilt, and isolation among affected individuals, discouraging them from seeking support or treatment options. Cultural norms and religious beliefs may also influence perceptions of IVF, further complicating the decision-making process for couples facing infertility challenges. Overcoming social stigma requires comprehensive awareness campaigns and education initiatives aimed at fostering open dialogue and promoting acceptance of diverse fertility paths within Egyptian communities.

Market Segmentation Analysis:

By Product:

The Egypt In-Vitro Fertilization (IVF) market can be segmented by product into equipment, reagents and media, and accessories. Equipment includes essential tools such as incubators, microscopes, and cryogenic storage systems used in the IVF laboratory. Reagents and media encompass culture media, cryoprotectants, and hormonal supplements vital for embryo development and preservation. Accessories comprise consumables like pipettes, dishes, and tubes necessary for handling gametes and embryos during the IVF process. Each product segment plays a crucial role in facilitating successful IVF procedures, with advancements in technology and formulations continually enhancing efficiency and outcomes. As demand for IVF services grows in Egypt, driven by factors like increasing infertility rates and rising awareness, the market for IVF products is poised for expansion, presenting opportunities for manufacturers and suppliers to meet the evolving needs of fertility clinics and laboratories across the country.

By Cycle:

The Egypt In-Vitro Fertilization (IVF) market can also be segmented based on the type of cycle, including fresh non-donor IVF cycles, frozen non-donor IVF cycles, frozen donor IVF cycles, and fresh donor IVF cycles. Fresh non-donor IVF cycles involve using the patient’s own eggs and sperm for fertilization, while frozen non-donor cycles utilize previously frozen embryos. Frozen donor IVF cycles utilize donated embryos, either from anonymous or known donors, that have been cryopreserved. Fresh donor IVF cycles involve using donated eggs from a donor for fertilization. Each cycle type presents unique considerations in terms of patient selection, treatment protocols, and success rates, catering to the diverse needs and circumstances of individuals seeking fertility treatments in Egypt. As demand for IVF services continues to rise, driven by factors like changing societal trends and advancements in reproductive technology, the market for different cycle types is expected to witness growth, reflecting the evolving landscape of assisted reproductive services in the country.

Segments:

Based on Product

  • Equipment
  • Reagents and Media
  • Accessories

Based on Cycle

  • Fresh Non-donor IVF Cycles
  • Frozen Non-donor IVF Cycles
  • Frozen Donor IVF Cycles
  • Fresh Donor IVF Cycle

Based on Type

  • Conventional IVF
  • IVF with ICSI
  • IVF with Donar Eggs
  • Others

Based on End-User

  • Fertility Clinics
  • Hospitals & Surgical Centers
  • Cryobanks
  • Research Institutes

Based on the Geography:

  • Greater Cairo region
  • Delta region
  • Alexandria and Matrouh region
  • Upper Egypt region

Regional Analysis

Greater Cairo region

The Greater Cairo region, encompassing the capital city and its surrounding areas, holds the lion’s share of the Egyptian IVF market, accounting for approximately 45% of the overall market. This region boasts a high concentration of fertility clinics and advanced healthcare facilities, catering to the growing demand for IVF services among urban populations.

Delta region

The Delta region, comprising governorates like Dakahlia, Gharbia, and Kafr El-Sheikh, accounts for around 20% of the market share. This region has witnessed a gradual increase in awareness and acceptance of IVF treatments, driven by improving healthcare infrastructure and rising disposable incomes.

Alexandria and Matrouh region

The Alexandria and Matrouh region, including the Mediterranean coastal cities, holds a market share of approximately 15%. This region attracts patients from neighboring countries seeking high-quality IVF services, contributing to the market’s growth.

Upper Egypt region

The Upper Egypt region, encompassing governorates like Assiut, Sohag, and Qena, accounts for around 12% of the market share. While this region has traditionally lagged in terms of IVF adoption, efforts by healthcare authorities and increasing awareness have led to a gradual uptake of these services.

Key Player Analysis

  1. Thermo Fisher Scientific, Inc.
  2. Cook Medical, Inc.
  3. Cyprus IVF Centre
  4. Oxford Gene Technology
  5. Lifesure Fertility & Gynaecology Centre
  6. Vitrolife AB
  7. Genea Biomedx
  8. Irvine Scientific
  9. EMD Serono, Inc.
  10. BioART Fertility Centre
  11. Cooper Surgical
  12. Jetanin Institute for Assisted Reproduction
  13. OvaScience, Inc.
  14. Siriraj Hospital
  15. Ramathibodi Hospital
  16. Trakya University Hospital ART Center
  17. Auxogyn
  18. Bangkok Fertility Center
  19. Al Bushra Medical Specialty Complex

Competitive Analysis

In the competitive landscape of the Egypt In-Vitro Fertilization (IVF) market, several leading players dominate with their extensive product portfolios, advanced technologies, and established reputations. Thermo Fisher Scientific, Inc., a prominent player in the field, offers a comprehensive range of IVF-related products and solutions, leveraging its strong global presence and innovative research initiatives. Cook Medical, Inc. is another key competitor, renowned for its high-quality medical devices and specialized fertility treatments. Cyprus IVF Centre stands out for its expertise in reproductive medicine and personalized patient care, attracting both local and international clientele. Additionally, companies like Vitrolife AB, Irvine Scientific, and EMD Serono, Inc. are notable contenders, contributing to market growth through their cutting-edge technologies and strategic partnerships. As competition intensifies, these leading players continue to drive innovation and enhance accessibility to IVF services, shaping the dynamics of the Egyptian IVF market with their diverse offerings and competitive strategies.

Recent Developments

In June 2023, the launch of United States-based MilliporeSigma’s novel CellToxTM Assay Platform was declared. The platform comprises a collection of IVF tests to check the security of products and medicines.

In May 2023, WuXi AppTec was introduced in China and its in vitro toxicant abilities were proliferated. Analysis was included as a segment of the expansion and a novel service for making customized in vitro assays is to be declared.

In April 2023, Thermo Fisher Scientific Inc., based in the United States, acquired CooperSurgical, a dominant IVF provider. This purchase considerably strengthened Thermo Fisher’s share in the IVF industry, improving its competition.

In March 2023, Sweden-based Vitrolife published that it received FDA approval on its Cryotop vitrification equipment. It is an innovative procedure for vitrifying embryos.

Market Concentration & Characteristics

The Egypt In-Vitro Fertilization (IVF) market exhibits characteristics of moderate market concentration, with several key players dominating the landscape while allowing room for smaller clinics and laboratories to thrive. Leading IVF centers such as Cairo Fertility Center, Egyptian IVF-ET Center, and El-Refaey Fertility & Endoscopy Center command significant market share due to their extensive experience, advanced technologies, and established reputations for high success rates. These established players often set industry standards and drive innovation through research and development initiatives. Despite the presence of these major players, the market remains dynamic, with new entrants continuously emerging and niche clinics catering to specific patient needs. This diversity in the market fosters healthy competition and ensures that patients have access to a variety of IVF services tailored to their preferences and requirements. As the market evolves, maintaining a balance between market concentration and diversity is essential to fostering innovation, improving accessibility, and advancing the overall quality of IVF services in Egypt.

Report Coverage

The research report offers an in-depth analysis based on Product, Cycle, Type, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

  1. Continued Growth: The Egypt IVF market is projected to experience steady growth driven by factors like increasing infertility rates and rising awareness of fertility treatments.
  2. Technological Advancements: Ongoing advancements in IVF techniques and technologies are expected to improve success rates and expand treatment options for patients.
  3. Accessibility Improvements: Efforts to enhance accessibility to IVF services, such as government initiatives and improved healthcare infrastructure, are anticipated to increase treatment uptake.
  4. Rising Demand for Donor IVF Cycles: Demand for donor IVF cycles, both fresh and frozen, is likely to increase as more couples opt for assisted reproductive options.
  5. Medical Tourism Growth: Egypt’s potential as a medical tourism destination for IVF treatment may see a surge, driven by lower costs and improving healthcare standards.
  6. Focus on Quality of Care: There will be an increasing emphasis on providing high-quality care and personalized treatment plans to optimize patient outcomes.
  7. Addressing Affordability Challenges: Efforts to address the high cost of IVF treatments through subsidies, insurance coverage, or financial assistance programs may emerge.
  8. Regulatory Landscape: Regulatory frameworks governing IVF practices may evolve to ensure patient safety, ethical standards, and industry accountability.
  9. Embracing Genetic Testing: Adoption of preimplantation genetic testing (PGT) and other genetic screening techniques may become more widespread to improve embryo selection and minimize genetic disorders.
  10. Collaboration and Partnerships: Collaboration between IVF clinics, research institutions, and industry stakeholders may increase, fostering innovation and knowledge sharing to drive advancements in the field.

CHAPTER NO. 1 : INTRODUCTION 15
1.1.1. Report Description 15
Purpose of the Report 15
USP & Key Offerings 15
1.1.2. Key Benefits for Stakeholders 15
1.1.3. Target Audience 16
1.1.4. Report Scope 16
CHAPTER NO. 2 : EXECUTIVE SUMMARY 17
2.1. Egypt In-Vitro Fertilization (IVF) Market Snapshot 17
2.1.1. Egypt In-Vitro Fertilization (IVF) Market, 2018 – 2032 (USD Million) 18
CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 19
3.1. Russia-Ukraine and Israel-Palestine War Impacts 19
CHAPTER NO. 4 : EGYPT IN-VITRO FERTILIZATION (IVF) MARKET – INDUSTRY ANALYSIS 20
4.1. Introduction 20
4.2. Market Drivers 21
4.2.1. Driving Factor 1 Analysis 21
4.2.2. Driving Factor 2 Analysis 22
4.3. Market Restraints 23
4.3.1. Restraining Factor Analysis 23
4.4. Market Opportunities 24
4.4.1. Market Opportunity Analysis 24
4.4.2. Market trends for IVF clinics in Egypt 24
4.5. Porter’s Five Forces Analysis 25
CHAPTER NO. 5 : ANALYSIS COMPETITIVE LANDSCAPE 26
5.1. Company Market Share Analysis – 2023 26
5.1.1. Egypt In-Vitro Fertilization (IVF) Market: Company Market Share, by Volume, 2023 26
5.1.2. Egypt In-Vitro Fertilization (IVF) Market: Company Market Share, by Revenue, 2023 27
5.1.3. Egypt In-Vitro Fertilization (IVF) Market: Top 6 Company Market Share, by Revenue, 2023 27
5.1.4. Egypt In-Vitro Fertilization (IVF) Market: Top 3 Company Market Share, by Revenue, 2023 28
5.2. Egypt In-Vitro Fertilization (IVF) Market Company Revenue Market Share, 2023 29
5.3. Company Assessment Metrics, 2023 30
5.3.1. Stars 30
5.3.2. Emerging Leaders 30
5.3.3. Pervasive Players 30
5.3.4. Participants 30
5.4. Start-ups /SMEs Assessment Metrics, 2023 30
5.4.1. Progressive Companies 30
5.4.2. Responsive Companies 30
5.4.3. Dynamic Companies 30
5.4.4. Starting Blocks 30
5.5. Strategic Developments 31
5.5.1. Acquisitions & Mergers 31
New Product Launch 31
Egypt Expansion 31
5.6. Key Players Product Matrix 32
CHAPTER NO. 6 : PESTEL & ADJACENT MARKET ANALYSIS 33
6.1. PESTEL 33
6.1.1. Political Factors 33
6.1.2. Economic Factors 33
6.1.3. Social Factors 33
6.1.4. Technological Factors 33
6.1.5. Environmental Factors 33
6.1.6. Legal Factors 33
6.2. Adjacent Market Analysis 33
CHAPTER NO. 7 : EGYPT IN-VITRO FERTILIZATION (IVF) MARKET – BY PRODUCT SEGMENT ANALYSIS 34
7.1. Egypt In-Vitro Fertilization (IVF) Market Overview, by Product Segment 34
7.1.1. Egypt In-Vitro Fertilization (IVF) Market Revenue Share, By Product, 2023 & 2032 35
7.1.2. Egypt In-Vitro Fertilization (IVF) Market Attractiveness Analysis, By Product 36
7.1.3. Incremental Revenue Growth Opportunity, by Product, 2024 – 2032 36
7.1.4. Egypt In-Vitro Fertilization (IVF) Market Revenue, By Product, 2018, 2023, 2027 & 2032 37
7.2. Equipment 38
7.3. Reagents and Media 39
7.4. Accessories 40
CHAPTER NO. 8 : EGYPT IN-VITRO FERTILIZATION (IVF) MARKET – BY CYCLE SEGMENT ANALYSIS 41
8.1. Egypt In-Vitro Fertilization (IVF) Market Overview, by Cycle Segment 41
8.1.1. Egypt In-Vitro Fertilization (IVF) Market Revenue Share, By Cycle, 2023 & 2032 42
8.1.2. Egypt In-Vitro Fertilization (IVF) Market Attractiveness Analysis, By Cycle 43
8.1.3. Incremental Revenue Growth Opportunity, by Cycle, 2024 – 2032 43
8.1.4. Egypt In-Vitro Fertilization (IVF) Market Revenue, By Cycle, 2018, 2023, 2027 & 2032 44
8.2. Fresh Non-donor IVF Cycles 45
8.3. Frozen Non-donor IVF Cycles 46
8.4. Frozen Donor IVF Cycles 47
8.5. Fresh Donor IVF Cycle 48
CHAPTER NO. 9 : EGYPT IN-VITRO FERTILIZATION (IVF) MARKET – BY TYPE SEGMENT ANALYSIS 49
9.1. Egypt In-Vitro Fertilization (IVF) Market Overview, by Type Segment 49
9.1.1. Egypt In-Vitro Fertilization (IVF) Market Revenue Share, By Type, 2023 & 2032 50
9.1.2. Egypt In-Vitro Fertilization (IVF) Market Attractiveness Analysis, By Type 51
9.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 51
9.1.4. Egypt In-Vitro Fertilization (IVF) Market Revenue, By Type, 2018, 2023, 2027 & 2032 52
9.2. Conventional IVF 53
9.3. IVF with ICSI 54
9.4. IVF with Donar Eggs 55
9.5. Others 56
CHAPTER NO. 10 : EGYPT IN-VITRO FERTILIZATION (IVF) MARKET – BY END-USER SEGMENT ANALYSIS 57
10.1. Egypt In-Vitro Fertilization (IVF) Market Overview, by End-User Segment 57
10.1.1. Egypt In-Vitro Fertilization (IVF) Market Revenue Share, By End-User, 2023 & 2032 58
10.1.2. Egypt In-Vitro Fertilization (IVF) Market Attractiveness Analysis, By End-User 59
10.1.3. Incremental Revenue Growth Opportunity, by End-User, 2024 – 2032 59
10.1.4. Egypt In-Vitro Fertilization (IVF) Market Revenue, By End-User, 2018, 2023, 2027 & 2032 60
10.2. Fertility Clinics 61
10.3. Hospitals & Surgical Centers 62
10.4. Cryobanks 63
10.5. Research Institutes 64
CHAPTER NO. 11 : COMPANY PROFILES 65
11.1. Thermo Fisher Scientific, Inc. 65
11.1.1. Company Overview 65
11.1.2. Product Portfolio 65
11.1.3. Swot Analysis 65
11.1.4. Business Strategy 66
11.1.5. Financial Overview 66
11.2. Cook Medical, Inc. 67
11.3. Cyprus IVF Centre 67
11.4. Oxford Gene Technology 67
11.5. Lifesure Fertility & Gynaecology Centre 67
11.6. Vitrolife AB 67
11.7. Genea Biomedx 67
11.8. Irvine Scientific 67
11.9. EMD Serono, Inc. 67
11.10. BioART Fertility Centre 67
11.11. Cooper Surgical 67
11.12. Jetanin Institute for Assisted Reproduction 67
11.13. OvaScience, Inc. 67
11.14. Siriraj Hospital 67
11.15. Ramathibodi Hospital 67
11.16. Trakya University Hospital ART Center 67
11.17. Auxogyn 67
11.18. Bangkok Fertility Center 67
11.19. Al Bushra Medical Specialty Complex 67
CHAPTER NO. 12 : RESEARCH METHODOLOGY 68
12.1. Research Methodology 68
12.1.1. Phase I – Secondary Research 69
12.1.2. Phase II – Data Modeling 69
Company Share Analysis Model 70
Revenue Based Modeling 70
12.1.3. Phase III – Primary Research 71
12.1.4. Research Limitations 72
Assumptions 72

List of Figures
FIG NO. 1. Egypt In-Vitro Fertilization (IVF) Market Revenue, 2018 – 2032 (USD Million) 18
FIG NO. 2. Porter’s Five Forces Analysis for Egypt In-Vitro Fertilization (IVF) Market 25
FIG NO. 3. Company Share Analysis, 2023 26
FIG NO. 4. Company Share Analysis, 2023 27
FIG NO. 5. Company Share Analysis, 2023 27
FIG NO. 6. Company Share Analysis, 2023 28
FIG NO. 7. Egypt In-Vitro Fertilization (IVF) Market – Company Revenue Market Share, 2023 29
FIG NO. 8. Egypt In-Vitro Fertilization (IVF) Market Revenue Share, By Product, 2023 & 2032 35
FIG NO. 9. Market Attractiveness Analysis, By Product 36
FIG NO. 10. Incremental Revenue Growth Opportunity by Product, 2024 – 2032 36
FIG NO. 11. Egypt In-Vitro Fertilization (IVF) Market Revenue, By Product, 2018, 2023, 2027 & 2032 37
FIG NO. 12. Egypt In-Vitro Fertilization (IVF) Market for Equipment, Revenue (USD Million) 2018 – 2032 38
FIG NO. 13. Egypt In-Vitro Fertilization (IVF) Market for Reagents and Media, Revenue (USD Million) 2018 – 2032 39
FIG NO. 14. Egypt In-Vitro Fertilization (IVF) Market for Accessories, Revenue (USD Million) 2018 – 2032 40
FIG NO. 15. Egypt In-Vitro Fertilization (IVF) Market Revenue Share, By Cycle, 2023 & 2032 42
FIG NO. 16. Market Attractiveness Analysis, By Cycle 43
FIG NO. 17. Incremental Revenue Growth Opportunity by Cycle, 2024 – 2032 43
FIG NO. 18. Egypt In-Vitro Fertilization (IVF) Market Revenue, By Cycle, 2018, 2023, 2027 & 2032 44
FIG NO. 19. Egypt In-Vitro Fertilization (IVF) Market for Fresh Non-donor IVF Cycles, Revenue (USD Million) 2018 – 2032 45
FIG NO. 20. Egypt In-Vitro Fertilization (IVF) Market for Frozen Non-donor IVF Cycles, Revenue (USD Million) 2018 – 2032 46
FIG NO. 21. Egypt In-Vitro Fertilization (IVF) Market for Frozen Donor IVF Cycles, Revenue (USD Million) 2018 – 2032 47
FIG NO. 22. Egypt In-Vitro Fertilization (IVF) Market for Fresh Donor IVF Cycle, Revenue (USD Million) 2018 – 2032 48
FIG NO. 23. Egypt In-Vitro Fertilization (IVF) Market Revenue Share, By Type, 2023 & 2032 50
FIG NO. 24. Market Attractiveness Analysis, By Type 51
FIG NO. 25. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 51
FIG NO. 26. Egypt In-Vitro Fertilization (IVF) Market Revenue, By Type, 2018, 2023, 2027 & 2032 52
FIG NO. 27. Egypt In-Vitro Fertilization (IVF) Market for Conventional IVF, Revenue (USD Million) 2018 – 2032 53
FIG NO. 28. Egypt In-Vitro Fertilization (IVF) Market for IVF with ICSI, Revenue (USD Million) 2018 – 2032 54
FIG NO. 29. Egypt In-Vitro Fertilization (IVF) Market for IVF with Donar Eggs, Revenue (USD Million) 2018 – 2032 55
FIG NO. 30. Egypt In-Vitro Fertilization (IVF) Market for Others, Revenue (USD Million) 2018 – 2032 56
FIG NO. 31. Egypt In-Vitro Fertilization (IVF) Market Revenue Share, By End-User, 2023 & 2032 58
FIG NO. 32. Market Attractiveness Analysis, By End-User 59
FIG NO. 33. Incremental Revenue Growth Opportunity by End-User, 2024 – 2032 59
FIG NO. 34. Egypt In-Vitro Fertilization (IVF) Market Revenue, By End-User, 2018, 2023, 2027 & 2032 60
FIG NO. 35. Egypt In-Vitro Fertilization (IVF) Market for Fertility Clinics, Revenue (USD Million) 2018 – 2032 61
FIG NO. 36. Egypt In-Vitro Fertilization (IVF) Market for Hospitals & Surgical Centers, Revenue (USD Million) 2018 – 2032 62
FIG NO. 37. Egypt In-Vitro Fertilization (IVF) Market for Cryobanks, Revenue (USD Million) 2018 – 2032 63
FIG NO. 38. Egypt In-Vitro Fertilization (IVF) Market for Research Institutes, Revenue (USD Million) 2018 – 2032 64
FIG NO. 39. Research Methodology – Detailed View 68
FIG NO. 40. Research Methodology 69

List of Tables
TABLE NO. 1. : Egypt In-Vitro Fertilization (IVF) Market: Snapshot 17
TABLE NO. 2. : Drivers for the Egypt In-Vitro Fertilization (IVF) Market: Impact Analysis 21
TABLE NO. 3. : Restraints for the Egypt In-Vitro Fertilization (IVF) Market: Impact Analysis 23

Frequently Asked Questions:

What is the current size of the Egypt In-Vitro Fertilization (IVF) Market?

The Egypt In-Vitro Fertilization (IVF) market was valued at USD 487.21 million in 2023 and is projected to reach USD 957.82 million by 2032, reflecting a robust compound annual growth rate of 7.80%.

What factors are driving the growth of the Egypt In-Vitro Fertilization (IVF) Market?

The growth of the Egypt IVF market is primarily driven by increasing awareness and acceptance of IVF procedures, rising infertility rates, advancements in IVF technologies, supportive government initiatives, and favorable reimbursement policies.

What are the key segments within the Egypt In-Vitro Fertilization (IVF) Market?

The key segments within the Egypt IVF market include product segments such as equipment, reagents and media, and accessories, as well as cycle-based segments like fresh non-donor IVF cycles, frozen non-donor IVF cycles, frozen donor IVF cycles, and fresh donor IVF cycles.

What are some challenges faced by the Egypt In-Vitro Fertilization (IVF) Market?

Challenges faced by the Egypt IVF market include the high cost of treatment, limited insurance coverage, social stigma surrounding infertility, ethical considerations, and the limited availability of qualified professionals.

Who are the major players in the Egypt In-Vitro Fertilization (IVF) Market?

Major players in the Egypt IVF market include Thermo Fisher Scientific, Inc., Cook Medical, Inc., Cyprus IVF Centre, Oxford Gene Technology, Vitrolife AB, and EMD Serono, Inc., among others.

Which segment is leading the market share?

Fertility clinics are the dominant service providers within the Egypt IVF market, catering to a larger share of patients compared to hospitals or research centers.

Single Use Upstream Bioprocessing Technology Market

Published:
Report ID: 41061

Viral Clearance and Testing Services Market

Published:
Report ID: 41070

Rare Kidney Diseases Market

Published:
Report ID: 41082

Single Use Bioreactors Market

Published:
Report ID: 41087

Oral Solid Dosage Manufacturing Market

Published:
Report ID: 41090

Plasmid DNA Manufacturing Market

Published:
Report ID: 41100

Nanoparticle Formulation Market

Published:
Report ID: 41106

Next Generation Drug Conjugates Market

Published:
Report ID: 41115

Lab Automation Market

Published:
Report ID: 41013

Sober Living Homes Market

Published:
Report ID: 40991

Radiopharmaceuticals Market

Published:
Report ID: 40978

Aptamers Therapeutics Technologies and Services Market

Published:
Report ID: 40945

Purchase Options

$999
Delivery Format: Excel.
$1999
Designed for the individual purchaser.
$2999
Users located at a single corporate site or regional office.
$3999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN